Related Experiment Video
Updated: Nov 29, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Anticoagulation-related nephropathy for the internist: a concise review
Kenechukwu Mezue1, Pradhum Ram2, Obiora Egbuche3
1Division of Hospital Medicine, Altru Health System Grand Forks, ND, USA.
Anticoagulation-related nephropathy (ARN) is a poorly understood condition. This review discusses diagnosis and management strategies for ARN, particularly concerning direct-acting oral anticoagulants (DOACs).
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Anticoagulation-related nephropathy (ARN) is a significant clinical entity with high morbidity and mortality.
- ARN is often underdiagnosed and inadequately managed.
- While associated with warfarin, ARN's link to direct-acting oral anticoagulants (DOACs) is less established but increasingly concerning.
Purpose of the Study:
- To review the current understanding of Anticoagulation-related nephropathy (ARN).
- To highlight diagnostic measures for prompt ARN identification.
- To propose therapeutic strategies for managing ARN, especially in the context of DOAC use.
Main Methods:
- Literature review focusing on Anticoagulation-related nephropathy (ARN).
- Analysis of existing case reports and studies on warfarin and DOAC-associated kidney injury.
- Synthesis of information on clinical presentation, diagnosis, and management.
Main Results:
- ARN can lead to accelerated progression to chronic kidney disease (CKD) and end-stage renal disease (ESRD).
- The association between DOACs and ARN is an emerging concern with expanding DOAC usage.
- Early diagnosis and intervention are crucial for managing ARN.
Conclusions:
- There is a need for increased awareness and improved diagnostic approaches for ARN.
- Proactive management strategies are essential to mitigate the burden of ARN.
- Further research is warranted to fully elucidate the role of DOACs in ARN and optimize treatment.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care

